Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval

Research output: Contribution to journalComment/debate

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)977-979
Number of pages3
JournalThe Lancet Psychiatry
Volume6
Issue number12
DOIs
StatePublished - Dec 2019

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this